A Phase 1 Study of GS-0189 (formerly FSI-189) as Monotherapy and in Combination with Rituximab inPatients with Relapsed/RefractoryNon-Hodgkin Lymphoma.

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science